Profound Medical Corp.
PROF
$4.71
$0.183.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.82% | 0.43% | -8.03% | 3.11% | -3.57% |
| Total Depreciation and Amortization | -6.25% | -0.22% | 58.45% | 46.43% | 10.89% |
| Total Amortization of Deferred Charges | -- | -- | -85.00% | -92.50% | -- |
| Total Other Non-Cash Items | -39.95% | -57.81% | -49.47% | -48.57% | -44.35% |
| Change in Net Operating Assets | 28.08% | 627.20% | 447.70% | 119.89% | 137.97% |
| Cash from Operations | -24.97% | -1.22% | -12.21% | 3.30% | 10.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -71.50% | -172.70% | -162.67% | -137.45% | -126.71% |
| Issuance of Common Stock | 69.15% | 2,229.50% | 761.22% | 710.78% | 765.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.31% | -- | -1,147.65% | -1,147.65% | -1,147.65% |
| Cash from Financing | 69.54% | 3,018.96% | 111.06% | 109.86% | 116.95% |
| Foreign Exchange rate Adjustments | -282.76% | -680.33% | -340.91% | -1,892.11% | 78.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 391.19% | 241.35% | 48.33% | 62.78% | 89.47% |